Distribution of Immune Cells Subsets in Healthy Females
NCT05609799 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2025-11-24
Summary
This study aims to evaluate the distribution of different lymphocyte subsets and other immune biomarkers in peripheral blood in healthy Danish females of reproductive age and to make a research biobank for future research. This data will serve as a reference to an ongoing study as well as future studies investigating the impact of the immune system on diseases affecting females in reproductive age.
Conditions
- Healthy
Interventions
- OTHER
-
Blood sample
Quantifying the volume of leucocyte subsets: NK-cells, B-cells, and T-cell subsets, including Treg, Th1, Th2 and Th17 in EDTA
Sponsors & Collaborators
-
Aalborg University Hospital
lead OTHER
Principal Investigators
-
Caroline Nørgaard-Pedersen, dr.med · Aalborg University Hospital, Denmark
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 41 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-11-01
- Primary Completion
- 2023-02-17
- Completion
- 2023-02-17
Countries
- Denmark
Study Locations
More Related Trials
-
Impact of Gender and Pubertal Status on Human Plasmacytoid Dendritic Cells. PLASMACYTOKID
NCT02956980 ·Status: TERMINATED ·Phase: NA
-
Collection of Immunology Specimens From Patients With Cancer or Blood Disorders, and Healthy Volunteers
NCT03207854 ·Status: RECRUITING
-
Lymphocytes Subpopulation in Cancer Patients
NCT02516371 ·Status: UNKNOWN ·Phase: NA
-
A Biospecimen Collection Study of Leukapheresis-Derived Circulating Tumor Cells, Immune Cells, and Progenitor Cells.
NCT00571389 ·Status: RECRUITING
-
Immunity to Infection in Healthy Participants and Participants With Cancer
NCT05787964 ·Status: ACTIVE_NOT_RECRUITING
-
Immune-Related Adverse Events and Associated Biomarkers in Patients Receiving Cancer Immunotherapy
NCT06089967 ·Status: COMPLETED
-
Immune Cell Response to Stimuli
NCT00397280 ·Status: RECRUITING
-
COVID-2019 Vaccine Immune Response Base on Single Cell Multi-Omics
NCT04871932 ·Status: RECRUITING
-
Identification of Innovative Biomarkers Related to the Immune System or Tumor Microenvironment to Promote the Efficacy of Immunotherapies
NCT06626269 ·Status: RECRUITING ·Phase: NA
-
Assessment of Blood and Follicular Fluid Immune Cell Constitution in Patients Undergoing in Vitro Fertilization
NCT01083745 ·Status: UNKNOWN
-
T Cells Response to SARS COV 2 Peptides
NCT04573348 ·Status: UNKNOWN
-
microRNA Profile in Umbilical Cord Blood NK Cells
NCT00751569 ·Status: UNKNOWN
-
Sequencing T-cells in Type I Diabetes Mellitus
NCT02040337 ·Status: COMPLETED
-
Early Detection of Complications During Immunotherapy for Haematological Malignancy
NCT06377059 ·Status: RECRUITING ·Phase: NA
-
Collection and Generation of Antigen-specific T-lymphocyte Cell Lines From Primary, Third-party, Related, and Unrelated Donors
NCT03114566 ·Status: TERMINATED
-
Predictive Markers of Response and Toxicity in Patients With a Haematological Malignancy Treated With Immunotherapy.
NCT05450367 ·Status: COMPLETED
-
Investigation of the Human Immune Response in Normal Subjects and Patients With Disorders of the Immune System and Cancer
NCT00001582 ·Status: COMPLETED
-
Human Blood Specimen Collection to Evaluate Immune Cell Function
NCT03422120 ·Status: COMPLETED
-
Sample Collection for Systems Evaluation of Patients With Unknown or Incompletely Characterized Immune Defects
NCT04408950 ·Status: COMPLETED
-
Prospective Study of White Blood Cells
NCT04838171 ·Status: RECRUITING
-
An Open Label Study of IgG Fc Glycan Composition in Human Immunity
NCT01967238 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Development of a Cell Culture Process for the Production of Human T-lymphocyte Precursors
NCT05118113 ·Status: UNKNOWN ·Phase: NA
-
Characterisation of TLR4+ Blood Cells in Patients With Solid Cancer
NCT06131775 ·Status: RECRUITING ·Phase: NA
-
COVID-19-Study of Immune Responses Following Vaccination Against SARS-CoV-2
NCT04836793 ·Status: UNKNOWN
-
Bank of Human Leukocytes From COVID-19 Convalescent Donors With an Anti-SARS-CoV-2 Cellular Immunity
NCT05458440 ·Status: RECRUITING ·Phase: NA